BHWM
IBRX icon

Bay Harbor Wealth Management’s ImmunityBio IBRX Stock Holding History

Bay Harbor Wealth Management’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$236 Buy
27
+20
+286% +$151 ﹤0.01% 1163
2026
Q1 		$53 Sell
7
-1
-13% -$7 ﹤0.01% 1251
2025
Q4 		$15 Sell
8
-3
-27% -$7 ﹤0.01% 1302
2025
Q3 		$27 Buy
11
+2
+22% +$5 ﹤0.01% 1263
2025
Q2 		$23 Buy
9
+3
+50% +$8 ﹤0.01% 1241
2025
Q1 		$18 Buy
+6
New +$18 ﹤0.01% 1127

Other funds holding IBRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bay Harbor Wealth Management's IBRX Position: Q2 2026 in Review

Bay Harbor Wealth Management increased its ImmunityBio (IBRX) stake by 286% in Q2 2026, buying an estimated $151 and bringing the position to 27 shares worth $236. The position accounts for ﹤0.01% of the portfolio, ranked #1163.

Bay Harbor Wealth Management first reported a position in IBRX in Q1 2025 and has held it in 6 quarters since. 404 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

  • Bay Harbor Wealth Management held 27 shares of ImmunityBio worth $236 as of Q2 2026.
  • Bay Harbor Wealth Management bought 20 ImmunityBio shares in Q2 2026, an estimated $151.
  • ImmunityBio made up ﹤0.01% of Bay Harbor Wealth Management's portfolio in Q2 2026, its #1163 holding.
  • Bay Harbor Wealth Management first reported a position in ImmunityBio in Q1 2025 and has held it in 6 quarters since.
  • 404 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Bay Harbor Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.